While some studies observed that high SRY sex--related high mobility group box (SOX)2, SOX2 expression was significantly associated with poor overall survival [118], according to other studies, the prognostic value of CD133 and SOX2 expression in advanced cancer remains unclear [119]. The gene discussed is SOX2; the disease is cancer.